← Open Payments lookup

DANIEL TAN: Open Payments

NPI 1811193766 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$36,444 in 252 payments from 16 companies in 2025. Trend: 2023 $33,054 · 2024 $34,640 · 2025 $36,444

Honoraria: $21,600Food & beverage: $6,796Travel & lodging: $5,186Speaker / faculty: $2,863
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.59$28,140
Noven Therapeutics, LLC11$3,072
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$837
E.R. Squibb & Sons, L.L.C.19$694
Otsuka America Pharmaceutical, Inc.22$670
Vanda Pharmaceuticals Inc.20$616
Axsome Therapeutics, Inc.16$510
Corium, LLC20$437
Lundbeck LLC16$410
Tris Pharma Inc14$389

Products named: Qelbree, Xelstrym, REXULTI, CAPLYTA, COBENFY, FANAPT, Auvelity, Azstarys.

Industry payments across TX — which companies pay providers there.